spacer
home > epc > Winter 2015
PUBLICATIONS

European Pharmaceutical Contractor

epc
Winter 2015

   
Text
PDF
bullet
Marketplace & Business
CRO Growth

Deal Me In


Contract research continues to thrive as CROs strengthen their R&D services and sponsors tighten their budgets. Growth is surging this year and predicted to at least the end of the decade, driven by the big players and market consolidation. EPC has more.
 
view
download pdf
bullet
Legal & Regulatory
Patent Protection

Optional Extras


It is uncertain times for patent portfolios in Europe, with pharma companies large and small working out whether to opt in or out of the Unifi ed Patent Court system, coming in 2017. The risks, rewards and – crucially – costs of the new regime must all be weighed up, says Paul Harris at Pillsbury Law.
 
view
download pdf
bullet
Science & Innovation
Business Models

Eco Friendly

A new ecosystem model is rapidly evolving in pharma and life sciences. Heather Fraser at IBM explains how it will require a level of collaboration the industry has not engaged in before, transcending boundaries and stimulating a growth in innovation.
 
view
download pdf
bullet
DATA MANAGEMENT
Q&A: Investigator Site Data

Joint Ventures


Through collaborative efforts such as the Shared Investigator Platform, biopharma partners are working to lessen administrative burdens for investigators and enhance the patient experience. Jackie Kent of Eli Lilly and TransCelerate talks to EPC.
 
view
download pdf
bullet
Risk Management
Pharmacovigilance

Progress Report


EPC offers a run-down of specific measures being implemented by the EMA to maximise the efficiency of the EudraVigilance safety reporting system for adverse events, following a significant decline in signals in 2014.
 
view
download pdf

Research and Development
Preclinical Development

Non-Clinics: Progression

Exploring the changing face of non-clinical development, Envigo's Lee Coney looks at the intricacies of investigating the safety and pharmacology of biologic drugs before they enter clinical trials, and the essential role of CRO players.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

c-LEcta signs Europe sales and distribution agreement with VWR for c-LEcta’s DENARASE®

• DENARASE® is now available through VWR’s sales channels in Europe • VWR, part of Avantor, is a leading global provider of product and service solutions to laboratory and production customers • Cooperation harbors the potential for c-LEcta’s product to gain additional share in a highly dynamic market
More info >>

White Papers

Translating Cancer Genomics Into A Personalised Approach For Cancer Patients

PRA Health Sciences (PRA)

Over the past few decades, the approach to prevention, diagnosis and treatment of cancer has radically shifted from organ-based to morphology-based and most recently, to genetics-based. Personalized or precision medicine (tailoring a treatment for a patient’s particular disease at a precise time point) is being performed every day at different levels in the clinical setting.
More info >>

Industry Events

4th Annual Genome Editing Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its 4thAnnual Genome Editing Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement